Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 5151

1.

Vaccines for Children in Low- and Middle-Income Countries.

Feikin DR, Flannery B, Hamel MJ, Stack M, Hansen PM.

In: Black RE, Laxminarayan R, Temmerman M, Walker N, editors. Reproductive, Maternal, Newborn, and Child Health: Disease Control Priorities, Third Edition (Volume 2). Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2016 Apr 05. Chapter 10.

2.

Diagnosis and Treatment of the Febrile Child.

Herlihy JM, D’Acremont V, Hay Burgess DC, Hamer DH.

In: Black RE, Laxminarayan R, Temmerman M, Walker N, editors. Reproductive, Maternal, Newborn, and Child Health: Disease Control Priorities, Third Edition (Volume 2). Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2016 Apr 05. Chapter 8.

3.

Local innate immune responses in the vaccine adjuvant-injected muscle.

Liang F, Loré K.

Clin Transl Immunology. 2016 Apr 29;5(4):e74. doi: 10.1038/cti.2016.19. eCollection 2016 Apr. Review.

4.

Broadly neutralizing epitopes in the Plasmodium vivax vaccine candidate Duffy Binding Protein.

Chen E, Salinas ND, Huang Y, Ntumngia F, Plasencia MD, Gross ML, Adams JH, Tolia NH.

Proc Natl Acad Sci U S A. 2016 May 18. pii: 201600488. [Epub ahead of print]

PMID:
27194724
5.

A single point in protein trafficking by Plasmodium falciparum determines the expression of major antigens on the surface of infected erythrocytes targeted by human antibodies.

Chan JA, Howell KB, Langer C, Maier AG, Hasang W, Rogerson SJ, Petter M, Chesson J, Stanisic DI, Duffy MF, Cooke BM, Siba PM, Mueller I, Bull PC, Marsh K, Fowkes FJ, Beeson JG.

Cell Mol Life Sci. 2016 May 19. [Epub ahead of print]

PMID:
27193441
6.

VAR2CSA domain-specific analysis of naturally acquired functional antibodies to P. falciparum placental malaria.

Doritchamou JY, Herrera R, Aebig JA, Morrison R, Nguyen V, Reiter K, Shimp R, MacDonald NJ, Narum DL, Fried M, Duffy PE.

J Infect Dis. 2016 May 18. pii: jiw197. [Epub ahead of print]

PMID:
27190180
7.

Analysis of the dose-dependent stage-specific in vitro efficacy of a multi-stage malaria vaccine candidate cocktail.

Boes A, Spiegel H, Kastilan R, Bethke S, Voepel N, Chudobová I, Bolscher JM, Dechering KJ, Fendel R, Buyel JF, Reimann A, Schillberg S, Fischer R.

Malar J. 2016 May 17;15(1):279. doi: 10.1186/s12936-016-1328-0.

8.
9.

Transmission blocking potency and immunogenicity of a plant-produced Pvs25-based subunit vaccine against Plasmodium vivax.

Blagborough AM, Musiychuk K, Bi H, Jones RM, Chichester JA, Streatfield S, Sala KA, Zakutansky SE, Upton LM, Sinden RE, Brian I, Biswas S, Sattabonkot J, Yusibov V.

Vaccine. 2016 May 10. pii: S0264-410X(16)30290-0. doi: 10.1016/j.vaccine.2016.05.007. [Epub ahead of print]

10.

Reduced immunogenicity of Plasmodium falciparum gamete surface antigen (Pfs48/45) in mice after disruption of disulfide bonds - evaluating effect of GILT.

Merino KM, Bansal GP, Kumar N.

Immunology. 2016 May 14. doi: 10.1111/imm.12621. [Epub ahead of print]

PMID:
27177843
12.

An antibody against an Anopheles albimanus midgut myosin reduces Plasmodium berghei oocyst development.

Lecona-Valera AN, Tao D, Rodríguez MH, López T, Dinglasan RR, Rodríguez MC.

Parasit Vectors. 2016 May 10;9(1):274. doi: 10.1186/s13071-016-1548-8.

13.

A Plasmodium Promiscuous T Cell Epitope Delivered within the Ad5 Hexon Protein Enhances the Protective Efficacy of a Protein Based Malaria Vaccine.

Fonseca JA, Cabrera-Mora M, Kashentseva EA, Villegas JP, Fernandez A, Van Pelt A, Dmitriev IP, Curiel DT, Moreno A.

PLoS One. 2016 Apr 29;11(4):e0154819. doi: 10.1371/journal.pone.0154819. eCollection 2016.

14.

Interrogating the Plasmodium Sporozoite Surface: Identification of Surface-Exposed Proteins and Demonstration of Glycosylation on CSP and TRAP by Mass Spectrometry-Based Proteomics.

Swearingen KE, Lindner SE, Shi L, Shears MJ, Harupa A, Hopp CS, Vaughan AM, Springer TA, Moritz RL, Kappe SH, Sinnis P.

PLoS Pathog. 2016 Apr 29;12(4):e1005606. doi: 10.1371/journal.ppat.1005606. eCollection 2016 Apr.

15.

RTS,S Malaria Vaccine and Increased Mortality in Girls.

Klein SL, Shann F, Moss WJ, Benn CS, Aaby P.

MBio. 2016 Apr 26;7(2). pii: e00514-16. doi: 10.1128/mBio.00514-16. No abstract available.

16.

Bacterial superglue enables easy development of efficient virus-like particle based vaccines.

Thrane S, Janitzek CM, Matondo S, Resende M, Gustavsson T, de Jongh WA, Clemmensen S, Roeffen W, van de Vegte-Bolmer M, van Gemert GJ, Sauerwein R, Schiller JT, Nielsen MA, Theander TG, Salanti A, Sander AF.

J Nanobiotechnology. 2016 Apr 27;14:30. doi: 10.1186/s12951-016-0181-1.

17.

CNS infection safety signal of RTS,S/AS01 and possible association with rabies vaccine.

Gessner BD, Wraith DC, Finn A.

Lancet. 2016 Apr 2;387(10026):1376. doi: 10.1016/S0140-6736(16)30081-2. No abstract available.

PMID:
27115819
18.

Defining rules of CD8(+) T cell expansion against pre-erythrocytic Plasmodium antigens in sporozoite-immunized mice.

Billman ZP, Kas A, Stone BC, Murphy SC.

Malar J. 2016 Apr 26;15(1):238. doi: 10.1186/s12936-016-1295-5.

19.

Dendritic Cells and Their Multiple Roles during Malaria Infection.

Amorim KN, Chagas DC, Sulczewski FB, Boscardin SB.

J Immunol Res. 2016;2016:2926436. doi: 10.1155/2016/2926436. Epub 2016 Mar 24. Review.

20.

Safety and Immunogenicity of ChAd63 and MVA ME-TRAP in West African children and infants.

Afolabi MO, Tiono AB, Adetifa UJ, Yaro JB, Drammeh A, Nébié I, Bliss C, Hodgson SH, Anagnostou NA, Sanou GS, Jagne YJ, Ouedraogo O, Tamara C, Ouedraogo N, Ouedraogo M, Njie-Jobe J, Diarra A, Duncan CJ, Cortese R, Nicosia A, Roberts R, Viebig NK, Leroy O, Lawrie AM, Flanagan KL, Kampman B, Bejon P, Imoukhuede EB, Ewer KJ, Hill AV, Bojang K, Sirima SB.

Mol Ther. 2016 Apr 25. doi: 10.1038/mt.2016.83. [Epub ahead of print]

PMID:
27109630
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk